FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Metoprolol tartrate (as metoprolol succinate) 25 mg prolonged-release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Metoprolol tartrate (as metoprolol succinate) 50 mg prolonged-release oral tablet Count of base of active ingredient False un Inferred relationship Some
    Metoprolol tartrate (as metoprolol succinate) 50 mg prolonged-release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely metoprolol tartrate (as metoprolol succinate) 100 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely metoprolol tartrate (as metoprolol succinate) 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely metoprolol tartrate (as metoprolol succinate) 200 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely metoprolol tartrate (as metoprolol succinate) 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely selinexor 20 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely selinexor 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely burosumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely burosumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely burosumab 30 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely burosumab 30 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely burosumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely burosumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely luspatercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely luspatercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely luspatercept 75 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely luspatercept 75 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Vaccine product containing only Neisseria meningitidis serogroup C capsular polysaccharide conjugated antigen (medicinal product) Count of active ingredient False un Inferred relationship Some
    Vaccine product containing only Neisseria meningitidis serogroup C antigen (medicinal product) Count of active ingredient False un Inferred relationship Some
    Polyestradiol only product Count of base of active ingredient False un Inferred relationship Some
    Fostemsavir only product Count of base of active ingredient False un Inferred relationship Some
    Fostemsavir only product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely fostemsavir 600 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely fostemsavir 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely mebendazole 500 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely mebendazole 500 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely pyrantel (as pyrantel pamoate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely triclabendazole 50 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely triclabendazole 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Benznidazole 100 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Benznidazole 100 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Benznidazole 12.5 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Benznidazole 12.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely clindamycin (as clindamycin palmitate hydrochloride) 15 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely clindamycin (as clindamycin palmitate hydrochloride) 15 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely abiraterone acetate 500 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely abiraterone acetate 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely adalimumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely adalimumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Triclabendazole 250 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Triclabendazole 250 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Benzylpenicillin (as benzylpenicillin potassium) 5 million unit powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Benzylpenicillin (as benzylpenicillin potassium) 5 million unit powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Cedazuridine 100 mg and decitabine 35 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Cedazuridine 100 mg and decitabine 35 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Miltefosine 50 mg oral capsule Count of base of active ingredient False un Inferred relationship Some
    Miltefosine 50 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely miltefosine 10 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely miltefosine 10 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Amphotericin B liposome 50 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Amphotericin B liposome 50 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Product containing precisely ledipasvir 90 milligram and sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely ledipasvir 90 milligram and sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Ledipasvir 45 mg and sofosbuvir 200 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Ledipasvir 45 mg and sofosbuvir 200 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Sofosbuvir 400 mg and velpatasvir 100 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Sofosbuvir 400 mg and velpatasvir 100 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely glecaprevir 100 milligram and pibrentasvir 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely glecaprevir 100 milligram and pibrentasvir 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Brexucabtagene autoleucel only product Count of base of active ingredient False un Inferred relationship Some
    Product containing only brexucabtagene autoleucel in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely afatinib (as afatinib dimaleate) 50 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely afatinib (as afatinib dimaleate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Agomelatine 25 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Agomelatine 25 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely phenazone 50 milligram/1 milliliter conventional release solution for ear drops (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely phenazone 50 milligram/1 milliliter conventional release solution for ear drops (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Bisacodyl 2 mg/mL rectal suspension Count of base of active ingredient False un Inferred relationship Some
    Bisacodyl 2 mg/mL rectal suspension Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing only agomelatine in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing only phenazone in otic dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Cinnarizine 25 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Cinnarizine 25 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely capecitabine 300 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely capecitabine 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Brivaracetam 75 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Brivaracetam 75 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Brivaracetam 50 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Brivaracetam 50 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Brivaracetam 25 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Brivaracetam 25 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely brivaracetam 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely brivaracetam 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Brivaracetam 100 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Brivaracetam 100 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Brigatinib 30 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Brigatinib 30 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely brigatinib 180 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely brigatinib 180 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely brigatinib 90 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely brigatinib 90 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Binimetinib 15 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Binimetinib 15 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Baricitinib 2 mg oral tablet Count of base of active ingredient False un Inferred relationship Some

    Start Previous Page 211 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start